ArticleOncoimmunology

Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.

Christopher T Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.